Hyperinsulinemia inhibits secretion of apo AI more efficiently than secretion of apoAII and apoE (insulin and secretion of apoproteins).
Goldsztajn
P
P
Department of Clinical Biochemistry, Collegium Medicum, Jagiellonian University, Kraków, Poland.
Guzdek
A
A
Kruszelnicka-Kwiatkowska
O
O
Guevara
I
I
Kwaśniak
M
M
Harwich
J
J
Piwowarska
W
W
Dembińska-Kieć
D016632:Apolipoprotein A-I / Q000097:blood*; D016633:Apolipoprotein A-II / Q000097:blood*; D001057:Apolipoproteins E / Q000097:blood*; D006528:Carcinoma, Hepatocellular; D002460:Cell Line; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood*; D007328:Insulin / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008113:Liver Neoplasms
D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D001057:Apolipoproteins E; D007328:Insulin; D008075:Lipoproteins, HDL